Results 81 to 90 of about 7,785 (171)

Clinical Outcomes of Ocular Toxoplasmosis-Associated Rhegmatogenous and Tractional Retinal Detachment. [PDF]

J Vitreoretin Dis
Hébert M, Caplan H, Yu MD, Wakabayashi T, Deaner JD, Mehta S, Klufas MA, Ho AC, Hsu J, Garg SJ, Gupta OP, Spirn MJ, Xu D, Dunn JP, Yonekawa Y.   +14 more
europepmc   +1 more source

Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients. [PDF]

BMC Ophthalmol, 2023
Nsiangani Lusambo N, Kaimbo Wa Kaimbo D, Ngoyi Mumba DM, de-la-Torre A.   +3 more
europepmc   +1 more source

Toxoplasmic granuloma within an epiretinal membrane in a patient with recurrent ocular toxoplasmosis. [PDF]

Am J Ophthalmol Case Rep
Rudzinski M, Cortalezzi J, Erhard M, Racca L, Couto C.   +4 more
europepmc   +1 more source

New Models for the Study of Ocular Toxoplasmosis. Comment on Ashander et al. Human Retinal Organoid Model of Ocular Toxoplasmosis. <i>Pathogens</i> 2025, <i>14</i>, 286. [PDF]

Pathogens
Bruschi F, Casini G.
europepmc   +1 more source

Dataset of fundus images for the diagnosis of ocular toxoplasmosis. [PDF]

Data Brief, 2023
Cardozo O, Ojeda V, Parra R, Mello-Román JC, Vázquez Noguera JL, García-Torres M, Divina F, Grillo SA, Villalba C, Facon J, Castillo Benítez VE, Castro Matto I, Aquino-Brítez D.   +12 more
europepmc   +1 more source

ABCA4-associated maculopathy suspected to be ocular toxoplasmosis. [PDF]

BMC Ophthalmol
Elsayed MEAA, Barone V, MacLaren RE.
europepmc   +1 more source

ROP16 Promotes Epithelial-Mesenchymal Transition-Like Changes in Ocular Toxoplasmosis via STAT3 and TGF-β1 Pathways. [PDF]

Transbound Emerg Dis
Song L, Xu L, Liu Y, Yang Y, Wang C, Zhang Y, Luo Q, Cao Y, Wang Y, Yu L.   +9 more
europepmc   +1 more source

Macular Pucker: A Devastating Complication in Ocular Toxoplasmosis. [PDF]

Cureus, 2023
Syed Mohd Khomsah SNH, Muhammed J, Wan Hitam WH.   +2 more
europepmc   +1 more source

Reply to Bruschi, F.; Casini, G. New Models for the Study of Ocular Toxoplasmosis. Comment on "Ashander et al. Human Retinal Organoid Model of Ocular Toxoplasmosis. <i>Pathogens</i> 2025, <i>14</i>, 286". [PDF]

Pathogens
Ashander LM, Smith JR.
europepmc   +1 more source

Intravitreal cotrimoxazole as adjuvant therapy for active ocular toxoplasmosis: a case series and literature review. [PDF]

J Ophthalmic Inflamm Infect
Hosseini SM, Azadmanesh A, Zamani G, Shariati MM.   +3 more
europepmc   +1 more source